Medical Therapy and Clinical Outcomes in Cardiac Sarcoidosis Patients With Systolic Heart Failure
GDMT optimization is associated with better cardiac remodeling and clinical outcomes in CS patients with HFrEF.
Authors
- Nikhil Kolluri (ORCID: https://orcid.org/0000-0001-9613-9637)
- Daniel Sykora (ORCID: https://orcid.org/0000-0002-6195-8541)
- Omar Abou Ezzeddine
- John R. Giudicessi (ORCID: https://orcid.org/0000-0001-5871-0265)
- Mohamed Y. Elwazir (ORCID: https://orcid.org/0000-0002-9168-5855)
- Melanie Bratcher
- John P. Bois (ORCID: https://orcid.org/0000-0003-4972-5160)
- Andrew N. Rosenbaum (ORCID: https://orcid.org/0000-0001-9202-0233)
- Robert Churchill (ORCID: https://orcid.org/0000-0002-6813-5492)
- Leslie T. Cooper (ORCID: https://orcid.org/0000-0003-1002-3313)
- Kathleen M. Young (ORCID: https://orcid.org/0000-0002-5358-8528)
- B Michelle Kim (ORCID: https://orcid.org/0009-0004-8025-3362)
- Sami Ryan
Institutions
- WinnMed (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- Circulation Journal
- Published
- 2024-09-02
- DOI
- https://doi.org/10.1253/circj.cj-24-0205
- Citations
- 7
- Primary Topic
- Sarcoidosis and Beryllium Toxicity Research
- Type
- article
- Field-Weighted Citation Impact
- 2.29